BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31997018)

  • 1. A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences.
    Muls A; Taylor A; Lalondrelle S; Kabir M; Norton C; Hart A; Andreyev HJ
    Support Care Cancer; 2020 Oct; 28(10):4881-4889. PubMed ID: 31997018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
    Andreyev HJN; Lalji A; Mohammed K; Muls ACG; Watkins D; Rao S; Starling N; Chau I; Cruse S; Pitkaaho V; Matthews J; Caley L; Pittordou V; Adams C; Wedlake L
    Support Care Cancer; 2021 Mar; 29(3):1443-1453. PubMed ID: 32676853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.
    Henson CC; Davidson SE; Ang Y; Babbs C; Crampton J; Kelly M; Lal S; Limdi JK; Whatley G; Swindell R; Makin W; McLaughlin J
    Support Care Cancer; 2013 Aug; 21(8):2255-65. PubMed ID: 23512314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes from treating bile acid malabsorption using a multidisciplinary approach.
    Gupta A; Muls AC; Lalji A; Thomas K; Watson L; Shaw C; Andreyev HJ
    Support Care Cancer; 2015 Oct; 23(10):2881-90. PubMed ID: 25693765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
    Andreyev HJ; Vlavianos P; Blake P; Dearnaley D; Norman AR; Tait D
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1464-71. PubMed ID: 15927411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowel dysfunction in survivors of gynaecologic malignancies.
    Ribas Y; Bonet M; Torres L; Núñez M; Esther Jovell-Fernández E; Aranda E; Andreyev HJ
    Support Care Cancer; 2020 Nov; 28(11):5501-5510. PubMed ID: 32172408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.
    Andreyev HJ; Davidson SE; Gillespie C; Allum WH; Swarbrick E; ; ; ;
    Gut; 2012 Feb; 61(2):179-92. PubMed ID: 22057051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling.
    Muls AC
    Acta Oncol; 2014 Mar; 53(3):297-306. PubMed ID: 24460087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy.
    Gillespie C; Goode C; Hackett C; Andreyev HJ
    Aliment Pharmacol Ther; 2007 Aug; 26(4):555-63. PubMed ID: 17661759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
    Raahave D
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How patients manage gastrointestinal symptoms after pelvic radiotherapy.
    Gami B; Harrington K; Blake P; Dearnaley D; Tait D; Davies J; Norman AR; Andreyev HJ
    Aliment Pharmacol Ther; 2003 Nov; 18(10):987-94. PubMed ID: 14616164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal consequences of cancer treatment: evaluation of 10 years' experience at a tertiary UK centre.
    Gadhok R; Paulon E; Tai C; Olushola T; Barragry J; Rahman F; Di Caro S; Mehta S
    Frontline Gastroenterol; 2021; 12(6):471-477. PubMed ID: 34712464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and treatment of chronic bowel symptoms following cancer in the colon and pelvic organs.
    Larsen HM; Borre M; Christensen P; Mohr Drewes A; Laurberg S; Krogh K; Fassov J
    Acta Oncol; 2019 May; 58(5):776-781. PubMed ID: 30698052
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology.
    Danielsson A; Nyhlin H; Persson H; Stendahl U; Stenling R; Suhr O
    Gut; 1991 Oct; 32(10):1180-7. PubMed ID: 1955174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
    Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
    Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?
    Muls AC; Lalji A; Marshall C; Butler L; Shaw C; Vyoral S; Mohammed K; Andreyev HJ
    Clin Med (Lond); 2016 Jun; 16(3):240-6. PubMed ID: 27251913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT.
    Gessler S; King M; Lemma A; Barber J; Jones L; Dunning S; Madden V; Pilling S; Hunter R; Fonagy P; Summerville K; MacDonald N; Olaitan A; Lanceley A
    Health Technol Assess; 2019 Feb; 23(6):1-92. PubMed ID: 30798790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers.
    Kuku S; Fragkos C; McCormack M; Forbes A
    Br J Cancer; 2013 Sep; 109(6):1504-12. PubMed ID: 24002603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.
    Lind H; Waldenström AC; Dunberger G; al-Abany M; Alevronta E; Johansson KA; Olsson C; Nyberg T; Wilderäng U; Steineck G; Åvall-Lundqvist E
    Br J Cancer; 2011 Sep; 105(6):737-45. PubMed ID: 21847122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.